Cargando…

Longitudinal analysis of cardiac structure and function in incident-automated peritoneal dialysis: comparison between icodextrin solution and glucose-based solution

BACKGROUND: This study aimed to evaluate the longitudinal changes in cardiac structure and function in incident-automated peritoneal dialysis (APD) patients. METHODS: We conducted a 2-year prospective, randomized, open-label, parallel-group study to compare the efficacy of icodextrin solution versus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jin-Bor, Cheng, Ben-Chung, Liu, Wen-Hao, Liao, Shang-Chih, Fu, Mao-Young Morgan, Moi, Sin-Hua, Yang, Cheng-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941563/ https://www.ncbi.nlm.nih.gov/pubmed/29739354 http://dx.doi.org/10.1186/s12882-018-0912-7

Ejemplares similares

Sex Modulates Cardiovascular Effects of Icodextrin-Based Peritoneal Dialysis Solutions
por: Paniagua, Ramón, et al.
Publicado: (2022)

Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
por: Dousdampanis, Periklis, et al.
Publicado: (2013)

Clinical effects of icodextrin in peritoneal dialysis
por: Cnossen, Trijntje T., et al.
Publicado: (2008)

Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis
por: Stachowska-Pietka, Joanna, et al.
Publicado: (2023)

Influence of 4% icodextrin solution on peritoneal tissue response and adhesion formation
por: Klink, Christian D, et al.
Publicado: (2013)

Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study
por: Chang, Tae Ik, et al.
Publicado: (2016)

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload
por: Johnson, David Wayne, et al.
Publicado: (2001)

Biphasic Regulation of Lipid Metabolism: A Meta-Analysis of Icodextrin in Peritoneal Dialysis
por: Huang, Yan-Feng, et al.
Publicado: (2015)

The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis
por: Becker, Monika, et al.
Publicado: (2019)

Long Peritoneal Dialysis Dwells With Icodextrin: Kinetics of Transperitoneal Fluid and Polyglucose Transport
por: Olszowska, Anna, et al.
Publicado: (2019)

Peritoneal Protein Losses and Cytokine Generation in Automated Peritoneal Dialysis with Combined Amino Acids and Glucose Solutions
por: Tjiong, H. L., et al.
Publicado: (2007)

A comparative study of the effect of icodextrin based peritoneal dialysis and hemodialysis on lipid metabolism
por: Kadiroğlu, A. K., et al.
Publicado: (2013)

What could be the expected solute clearance with single exchange of icodextrin?
por: Jeloka, T. K., et al.
Publicado: (2014)

Icodextrin and spurious hyperglycemia in peritoneal dialysis patients: a hospital-wide attempt to prevent such errors
por: Asakura, Yusuke, et al.
Publicado: (2017)

A Novel Diagnostic Approach for Suspected Icodextrin Pleural Effusion in a Peritoneal Dialysis Patient
por: Onuigbo, Macaulay Amechi Chukwukadibia, et al.
Publicado: (2019)

Moderate hyperosmolar hyponatremia caused by excessive off-label use of icodextrin during peritoneal dialysis
por: Chaudhari, Harshad, et al.
Publicado: (2023)

Comparison of Icodextrin and 2.5% Glucose in Potassium Metabolism by Acute K(+) load via Dialysate in Continuous Ambulatory Peritoneal Dialysis Patients
por: Yi, Joo-Hark, et al.
Publicado: (2009)

Icodextrin Improves the Serum Potassium Profile with the Enhancement of Nutritional Status in Continuous Ambulatory Peritoneal Dialysis Patients
por: Yi, Joo-Hark, et al.
Publicado: (2009)

Use of Toll-like receptor assays for the detection of bacterial contaminations in icodextrin batches released for peritoneal dialysis
por: Hacine-Gherbi, Hêla, et al.
Publicado: (2017)

A randomized clinical trial to evaluate the effects of icodextrin on left ventricular mass index in peritoneal dialysis
por: Cordeiro, Lilian, et al.
Publicado: (2022)

Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018)

Effects of Icodextrin Solution (Adept(®)) on Ovarian Cancer Cell Proliferation in an In Vitro Model
por: Chen, Wen-Hsin, et al.
Publicado: (2022)

Longitudinal Changes of PAI-1, MMP-2, and VEGF in Peritoneal Effluents and Their Associations with Peritoneal Small-Solute Transfer Rate in New Peritoneal Dialysis Patients
por: Hao, Na, et al.
Publicado: (2019)

Bone Mineral Parameters in Peritoneal Dialysis Patients after Lowering Calcium Concentration in Dialysis Fluids: A Case Series in Patients Using Icodextrin
por: Verschuur, Lara C., et al.
Publicado: (2023)

Benefits of a Continuous Ambulatory Peritoneal Dialysis (CAPD) Technique with One Icodextrin-Containing and Two Biocompatible Glucose-Containing Dialysates for Preservation of Residual Renal Function and Biocompatibility in Incident CAPD Patients
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions
por: Kussmann, Manuel, et al.
Publicado: (2019)

Stability and compatibility of antibiotics in peritoneal dialysis solutions
por: So, Simon Wai Yin, et al.
Publicado: (2022)

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients
por: Cho, Yeoungjee, et al.
Publicado: (2014)

Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients
por: Su, Yu-Jen, et al.
Publicado: (2013)

Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study
por: Vychytil, Andreas, et al.
Publicado: (2008)

A Case of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient Receiving Peritoneal Dialysis With Icodextrin Exposure
por: Alotaibi, Manal E, et al.
Publicado: (2022)

Icodextrin-associated hepatotoxicity
por: Gungor, Ozkan, et al.
Publicado: (2011)

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions
por: Kussmann, M., et al.
Publicado: (2017)

Challenges and possible solutions to peritoneal dialysis use in Nigeria
por: Ajayi, Samuel, et al.
Publicado: (2020)

Is Assisted Peritoneal Dialysis a Solution for Northern Manitoba?
por: Lavoie, Josée G., et al.
Publicado: (2019)

Glycine improves peritoneal vasoreactivity to dialysis solutions in the elderly
por: Zakaria, El Rasheid, et al.
Publicado: (2019)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Relationship between Kt/V urea-based dialysis adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients
por: Chen, Jin-Bor, et al.
Publicado: (2012)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_frcs62e4qp7cvq9i26mcbrfof3